Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 178

Results For "organ"

1953 News Found

Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22
News | October 29, 2021

Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22

Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021


Finvasia acquires Gini Health as it moves into healthcare tech
Digitisation | October 29, 2021

Finvasia acquires Gini Health as it moves into healthcare tech

Gini Health works in the domain of personalised healthcare


Boehringer Ingelheim announces EMA marketing authorisation for spesolimab
Drug Approval | October 29, 2021

Boehringer Ingelheim announces EMA marketing authorisation for spesolimab

Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules


Transforming Healthcare Through AI
Opinion | October 29, 2021

Transforming Healthcare Through AI


Rainbow hospital gives new lease of life to infant on ECMO support
Healthcare | October 28, 2021

Rainbow hospital gives new lease of life to infant on ECMO support

The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease


Honeywell launches real-time health monitoring system
Digitisation | October 28, 2021

Honeywell launches real-time health monitoring system

Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent


WHO selects Medigen’s Covid-19 vaccine for solidarity trial
Biotech | October 27, 2021

WHO selects Medigen’s Covid-19 vaccine for solidarity trial

Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial


Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore
Clinical Trials | October 27, 2021

Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore

Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21


4baseCare partners with U.S. based Cellworks for personalised cancer care
Digitisation | October 27, 2021

4baseCare partners with U.S. based Cellworks for personalised cancer care

The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.


PLI scheme has the potential to make India a pharma hub: Dr Mandaviya
Policy | October 27, 2021

PLI scheme has the potential to make India a pharma hub: Dr Mandaviya

FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year